SAMANTHA BONO: Open Payments
NPI 1336424530 · NORTH PORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 22 payments from 11 companies in 2025. Trend: 2023 $197 · 2024 $648 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $95 |
| Amgen Inc. | 3 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $59 |
| GENZYME CORPORATION | 2 | $55 |
| MERZ NORTH AMERICA, INC. | 2 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| STRATA Skin Sciences, Inc. | 1 | $20 |
Products named: OTEZLA, SKYRIZI, BLU-U, DUPIXENT, Xeomin, TALTZ, COSENTYX, RINVOQ.
Industry payments across FL — which companies pay providers there.
